Clinical trial
Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal…
NCT00400114 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00400114 |
|---|---|
| Title | Sutent Following Chemotherapy, Radiation and Surgery For Resectable Esophageal Cancer |
| Official title | Adjuvant Sutent Following Chemotherapy, Radiation and Surgery For Esophageal Cancer, A Phase II Trial (ASSET) |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Irinotecan, Cisplatin, Radiation, Surgery, sunitinib (Sutent) |
| Enrollment | 36 |
| Start date | Sep 25, 2006 |
| Primary completion | Sep 19, 2016 |
| Completion | Sep 19, 2016 |
| First posted | Nov 16, 2006 |
| Last update posted | May 8, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: